Pixelgen
Stockholm, SE · Founded 2020 · 45 employees on LinkedIn · 2 known investors
Find your way into Pixelgen
Sign up to see every warm intro you have to Pixelgen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pixelgen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
Founders & leadership
Investors · 2
How we know: Industrifonden's portfolio page · funding news feeds · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Navigare Ventures's portfolio page · funding news feeds · open dataset · 5k.vc investor directory · Not right? Tell us
In the news
Frequently asked questions
- What does Pixelgen do?
- Pixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
- Who are Pixelgen's investors?
- Pixelgen's investors include Industrifonden, Navigare Ventures.
- Where is Pixelgen headquartered?
- Pixelgen is headquartered in Stockholm, SE.



